Browse Physical sciences topic

Subtopics (9)

• Contracts
• Government finance
• Observations
• Reports
• Research
• Securities
• Study and teaching
• Tests, problems and exercises
• Usage

Articles

Title	Author	Type	Date	Words
Physical science in constructivist early childhood classrooms.	Kato, Tsuguhiko; Van Meeteren, Beth Dykstra		Jun 22, 2008	1818
A new report from the National Academies' National Research Council, Controlling the Quantum World, argues that the United States should increase its funding for atomic, molecular and optical (AMO) science.		Brief article	Jul 31, 2006	145
Ulrike Heydenreich: Thomas Barry Fine Arts.	Briggs, Patricia		Jun 22, 2005	544
Volcanoes.			Apr 11, 2005	4503
Gender differences in learning constructs, shifts in learning constructs, and their relationship to course achievement in a structured inquiry, yearlong college physics course for life science majors.	Cavallo, Ann M.L.; Rozman, Michelle; Potter, Wendell H.		Oct 1, 2004	7868
Relationships between inquiry-based teaching and physical science standardized test scores.	Tretter, Thomas R.; Jones, M. Gail		Nov 1, 2003	3972
Icicle waves go with the flow. (Physics).	Weiss, Peter Ulrich	Brief Article	Dec 14, 2002	202
Schools take flight for centennial. (Curriculum update: the latest developments in math, science, language arts and social studies).	Lorenzetti, Jennifer Patterson		Oct 1, 2002	402
San Diego public stocks. (Marketplace).		Statistical Data Included	Sep 16, 2002	3089
Advanced Tissue Sciences Announces Conference Call to Discuss Second Quarter Financial Results.			Aug 9, 2002	176
PhotoPoint PDT Targets Both Tumor Cells and Blood Vessels in Preclinical Breast Cancer Study; Results Published in August 1st Issue of Journal ``Cancer Research''.			Aug 6, 2002	738
Advanced Tissue Sciences Announces Its Registration Statement on Form S-3 Has Been Declared Effective.			Jun 21, 2002	418
Gail K. Naughton, Ph.D. Appointed Dean of the College of Business Administration At San Diego State University.			Jun 18, 2002	593
Advanced Tissue Sciences Files Shelf Registration.			Jun 11, 2002	461
Mission Research Corp.		Brief Article	Jun 10, 2002	118
Miravant and Bausch & Lomb Sign Letter of Intent to Review SnET2 Clinical Data With License Option in Ophthalmology.			Jun 10, 2002	778
Miravant Announces First Quarter Results.			May 15, 2002	1309
Advanced Tissue Sciences Issued Patent for NouriCel Process; First U.S. Patent to Cover Collection of Cell Conditioned Media for Cosmetic Use.			May 15, 2002	1055
Advanced Tissue Sciences Reports First Quarter Results.			May 13, 2002	1067
Advanced Tissue Sciences Endorses Partner Agreement.			May 9, 2002	610
ORTEC SUCCESSFULY DEFENDS EUROPEAN PATENT ON ORCEL.			May 1, 2002	359
Accelerating scientific discovery through computation and visualization II.	Devaney, Judith E.		May 1, 2002	13914
San Diego Public Stocks. (San Diego Marketplace).		Illustration	Apr 29, 2002	2863
Miravant's PhotoPoint PDT Arrests Tumor Growth by Destroying Tumor Blood Vessels.			Apr 4, 2002	699
ATS forms anti-aging market unit.	Webb, Marion	Brief Article	Apr 1, 2002	500
Miravant Announces Fourth Quarter and 2001 Results.			Mar 26, 2002	1529
Advanced Tissue Sciences Announces Plans to Realign the Organization to Address New Initiatives.			Mar 22, 2002	1119
Miravant's CEO Discusses Notice From Nasdaq.			Mar 8, 2002	891
Miravant Updates Status of PhotoPoint Development Programs; Company to conduct SnET2 clinical data analysis and pursue new funding sources.			Mar 6, 2002	980
Miravant Regains Rights to PhotoPoint SnET2.			Mar 5, 2002	489
Training for tense times: Security professionals at four companies discuss their violence response teams. (Focus on Employment).	Anderson, Teresa		Mar 1, 2002	3220
Advanced Tissue Sciences Announces Year-End Financial Results.			Feb 19, 2002	1797
Advanced Tissue Sciences Announces Effectiveness of S-3 Registration.			Feb 11, 2002	150
Correction to Advanced Tissue Sciences S-3 Registration Release.			Feb 11, 2002	63
Miravant Presents Results for Lead PhotoPoint Cardiovascular Drug MV0633.			Feb 6, 2002	690
Partnership for Public Warning Board Members Announced.			Jan 31, 2002	428
MITRE Joins Fortune's List Of '100 Best Companies To Work For'.			Jan 24, 2002	279
Miravant Announces Spending Reduction Program.			Jan 23, 2002	719
Miravant Announces Results of Phase III Study Of SnET2.			Jan 13, 2002	392
Miravant Initiates Phase II Clinical Trial in Dermatology; Psoriasis Patients Are Being Treated With New PhotoPoint Drug MV9411.			Jan 8, 2002	550
Adapting SCALE-UP at Coastal Carolina University: classroom and curriculum.	Burns, Teresa	Brief Article	Jan 1, 2002	106
Dermagraft Receives Reimbursement Pass-Through Code.			Dec 11, 2001	594
Conference Draws Momentum For National Warning Organization.			Nov 30, 2001	281
Advanced Tissue Sciences Demonstrates Improved Cardiac Function in Damaged Heart Tissue With Bio-Engineered Patch.			Nov 15, 2001	1003
Advanced Tissue Sciences Announces Third Quarter Financial Results.			Nov 13, 2001	1835
San Diego Public Stocks. (San Diego Marketplace).		Brief Article	Nov 12, 2001	3236
Proxy: Advanced Tissue Sciences Inc. (San Diego Marketplace).		Brief Article	Nov 12, 2001	420
Miravant's Intracoronary PhotoPoint PDT Inhibits Restenosis in Preclinical Studies.			Nov 12, 2001	813
Miravant Announces Third Quarter Results.			Nov 7, 2001	1255
Advanced Tissue Sciences Provides Corrected URL for Replay of Wall Street Analyst Forum Presentation.			Nov 6, 2001	88
Advanced Tissue Sciences Provides Corrected URL for Replay of Wall Street Analyst Forum.			Nov 6, 2001	113
Advanced Tissue Sciences Provides Corrected URL for Replay of Wall Street Analyst Forum Presentation.			Nov 6, 2001	113
Advanced Tissue Sciences Completes Private Placement of Stock.			Nov 5, 2001	648
Advanced Tissue Sciences to Present At Wall Street Analyst Forum.			Nov 2, 2001	103
Advanced Tissue Sciences Awarded $1.4 Million to Develop Tissue-Engineered Cartilage; Tissue Growth Process to Simulate Real-World Conditions, Create Stronger Cartilage.			Oct 31, 2001	784
Advanced Tissue Sciences Demonstrates Success of Tissue-Engineered Small-Diameter Blood Vessels.			Oct 23, 2001	813
CEO INTERVIEW: GARY KLEDZIK - MIRAVANT MEDICAL TECHNOLOGIES (MRVT).		Brief Article	Oct 9, 2001	89
Advanced Tissue Sciences Provides Business Update.			Oct 8, 2001	1449
Advanced Tissue Sciences to Provide Business Update At UBS Warburg Global Life Sciences Conference.			Oct 5, 2001	113
Miravant to Present at UBS Warburg Global Life Sciences Conference.			Oct 5, 2001	200
SCO Financial Group Announces Investment Opinion on Advanced Tissue Sciences.			Oct 4, 2001	384
Advanced Tissue Sciences Announces Collaboration With Medtronic, Inc. and $20 Million Investment by Medtronic Affiliate.			Oct 3, 2001	977
MITRE Recognized by AARP for Exemplary Practices Toward Older Workers.			Oct 2, 2001	456
Advanced Tissue Sciences Announces FDA Approval for Dermagraft in the Treatment of Diabetic Foot Ulcers.			Oct 1, 2001	978
Ashland Specialty Chemical Co.		Brief Article	Oct 1, 2001	18
Biozhem Announces Launch Date for Anti-Aging Skin Care System with NouriCel; Lindsay Wagner Completes Filming.			Sep 25, 2001	633
REPEAT/Biozhem Announces Launch Date for Anti-Aging Skin Care System with NouriCel; Lindsay Wagner Completes Filming.			Sep 25, 2001	640
SAN DIEGO PUBLIC STOCKS.		Brief Article	Sep 10, 2001	3362
Ashland Specialty Chemical, Dublin, OH, a division of Ashland, has purchased Polydyne's gel-coat business and assets. (Acquisitions, Expansions).		Brief Article	Sep 1, 2001	58
Advanced Tissue Sciences Announces Second Quarter Financial Results.			Aug 13, 2001	1619
Advanced Tissue Sciences Corrects Financial Table Header Information; Six Months Ended Sted Year Ended.			Aug 13, 2001	45
Miravant Announces Second Quarter Results.			Aug 9, 2001	1274
MITRE to License Tool to Accelerate the Implementation of Satellite-Based Area Navigation --RNAV-- Procedures.			Aug 8, 2001	284
Techvest Healthcare Conference to Feature 150 Companies.			Jun 19, 2001	643
Miravant Cardiovascular Appoints New President; Dr. Robert W. Scott joins Miravant from Eli Lilly.			Jun 18, 2001	581
Miravant Completes Enrollment in Clinical Trial for Topical PhotoPoint Drug.			Jun 14, 2001	411
Miravant to Start Clinical Trials of New Topical PhotoPoint Drug for Dermatology.			Jun 4, 2001	644
MITRE Releases Information Security Technology Prototypes.			Jun 1, 2001	295
Miravant Secures $20 Million Funding From Pharmacia; Pharmacia To Purchase PhotoPoint Drug SnET2 and Expand Line of Credit.			May 30, 2001	599
Human Based Collagen Submission for Injectable Applications.			May 16, 2001	714
Wrinkle Reduction Reported in Clinical Study of Solution Containing Human Growth Factors.			May 14, 2001	614
Miravant Announces First Quarter Results.			May 10, 2001	945
Advanced Tissue Sciences Announces First Quarter Financial Results.			May 1, 2001	1243
Ashland.		Brief Article	May 1, 2001	60
SAN DIEGO PUBLIC STOCKS.		Brief Article	Apr 30, 2001	3597
Northpoint Technology Passes FCC Mandated Independent Testing - Only Company to Do So.			Apr 24, 2001	603
Biotech Assigns Annual Report Design to Downtown Studio.	AGUILA, SANDRA	Brief Article	Apr 23, 2001	233
A COMPUTATIONAL STUDY OF p-N,N-DIMETHYLAMINOCINNALDEHYDE.		Brief Article	Apr 1, 2001	133
Miravant to Present at Thomas Weisel Partners Healthcare Conference.			Mar 30, 2001	151
Miravant Announces Fourth Quarter and 2000 Results.			Mar 26, 2001	1292
Miravant's PhotoPoint Targets Tumor Neovasculature.			Mar 26, 2001	375
Results of Miravant's Intravascular PhotoPoint Therapy for Atherosclerosis Presented at Cardiology Meeting.			Mar 19, 2001	386
H. Stewart Parker Chosen Western Washington Small Business Person of the Year.			Mar 15, 2001	529
When warming up causes cooling down.		Brief Article	Mar 3, 2001	287
Software Improves Foundry Gating Design Method.		Brief Article	Mar 1, 2001	301
Biozhem Cosmeceuticals Inc. Announces Cell Life Complex Test Results.			Feb 26, 2001	458
Miravant to Present at Roth Capital Partners Growth Stock Conference.			Feb 15, 2001	120
Miravant Presents Results of Intracoronary PhotoPoint Therapy for Restenosis.			Feb 7, 2001	674
Miravant Announces Non-Binding Letter of Intent for Additional Funding & Continuation of Macular Degeneration Trials to Two-Year Endpoint.			Jan 22, 2001	557
Miravant to Present At December 18 Healthcare Conference.			Dec 15, 2000	132